Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the AMICUS Red Blood Cell Exchange (RBCx) System in Sickle Cell Patients

NCT02372877 is registered in ClinicalTrials.gov with Fenwal, Inc. as lead sponsor.

NCT NCT02372877
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02372877 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the AMICUS Red Blood Cell Exchange (RBCx) System in Sickle Cell Patients
Lead sponsor
Fenwal, Inc.
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2015
Completion date
January 19, 2018
Enrollment
83 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

sickle cell anemia